Hip Denervation in Juvenile Idiopathic Arthritis With Hip Arthritis
Status:
Completed
Trial end date:
2021-04-06
Target enrollment:
Participant gender:
Summary
Patients having juvenile idiopathic arthritis (according to ILAR criteria) with hip arthritis
were divided into two groups. Group 1 received hip denervation and group 2 controlled and
received a subcutaneous injection of saline. Outcome measures included pain, tenderness,
range of motion, range of motion, HARISS score. These outcomes were measured at baseline, 2
weeks, and 12 weeks